碘充足孕妇甲状腺功能参考值及甲状腺结节对TSH和fT4的影响
该前瞻性纵向研究纳入400例无甲状腺疾病史的孕妇,建立妊娠三期TSH和fT4参考区间,并分析甲状腺结节对甲状腺功能的影响。结果显示结节患病率28.8%,且结节与孕期持续较低的TSH值相关。
要点
- 妊娠三期TSH参考区间分别为0.13-4.16、0.31-3.73、0.58-4.36 mIU/L。
- 妊娠三期fT4参考区间分别为0.85-1.24、0.82-1.20、0.67-1.06 ng/dL。
- 甲状腺结节患病率28.8%,且与孕期TSH值持续较低相关。
核心结论
- 建立了本地区碘充足孕妇妊娠三期TSH和fT4的参考区间,有助于孕期甲状腺功能异常的恰当诊断。
- 碘充足孕妇中甲状腺结节患病率较高,且与整个孕期较低的TSH值相关。
研究设计与样本
- 前瞻性纵向研究,纳入400例无甲状腺疾病史且未服用影响甲状腺功能药物的孕妇。
- 每孕期采用化学发光免疫分析法检测TSH、fT4、抗甲状腺球蛋白抗体和抗甲状腺过氧化物酶抗体,孕早期检测尿碘浓度并进行甲状腺超声。
主要发现
- 孕早、中、晚期TSH参考区间分别为0.13-4.16、0.31-3.73、0.58-4.36 mIU/L。
- 孕早、中、晚期fT4参考区间分别为0.85-1.24、0.82-1.20、0.67-1.06 ng/dL。
- 甲状腺结节总患病率为28.8%(95%CI 24.4-33.5%),临床显著结节占6.0%。
- 有结节孕妇(n=115)孕期各阶段TSH中位数均低于无结节者(n=285):孕早期1.14 vs 1.48 mIU/L,p<0.001;孕中期1.22 vs 1.45 mIU/L,p=0.001;孕晚期1.74 vs 1.93 mIU/L,p=0.041。
- 有结节孕妇孕早期fT4均值高于无结节者(1.08±0.14 vs 1.03±0.12 ng/dL,p<0.001)。
关键数值与推荐
- 排除多胎妊娠、甲状腺自身免疫阳性、孕早期TSH>5或<0.1 mIU/L且同时fT4高于普通人群参考值、或临床显著结节(结节≥1 cm和/或多发结节)者以建立参考值。
临床怎么用
- 应采用妊娠期特异性且基于本实验室方法的TSH和fT4参考区间评估孕期甲状腺功能。
- 孕期发现甲状腺结节时,需注意其可能与较低的TSH值相关,解读甲状腺功能时应考虑此影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thyroid function assessment in pregnancy requires specific reference intervals stratified by gestational age and according to each laboratory method. Thyroid nodules may influence thyroid function in pregnant women. The aims of this study were to define the reference values of thyrotropin (TSH) and free thyroxine (fT4) in the three pregnancy trimesters in iodine-sufficient pregnant women, and to analyze the influence of thyroid nodules on thyroid function during pregnancy. METHODS: This was a prospective, longitudinal study comprising 400 pregnant women with no history of thyroid disease and no medication influencing thyroid function. TSH, fT4, antithyroglobulin, and antithyroid peroxidase antibodies were measured each trimester by chemiluminescent immunoassays. Urinary iodine concentration was measured in the first trimester when a thyroid echography was also performed. Women with multiple gestation pregnancies, positive thyroid autoimmunity, TSH values >5 or <0.1 mIU/L with a simultaneous fT4 level above the general population reference value in the first trimester, or clinically significant thyroid nodules (nodules ≥1 cm and/or multiple nodules) were excluded to establish TSH and fT4 reference values. RESULTS: Reference intervals in the first, second, and third trimesters were 0.13-4.16, 0.31-3.73, and 0.58-4.36 mIU/L, respectively, for TSH, and 0.85-1.24, 0.82-1.20, and 0.67-1.06 ng/dL, respectively, for fT4. The total prevalence of thyroid nodules was 28.8% [95% confidence interval (CI) 24.4-33.5%], and 6.0% of the participants showed clinically significant nodules. Pregnant women with thyroid nodules (n = 115) showed consistently lower TSH values during all pregnancy stages (first trimester: median 1.14 mIU/L [interquartile range (IQR) 0.53-1.75 mIU/L] vs. 1.48 mIU/L [IQR 0.94-2.19 mIU/L], p < 0.001; second trimester: 1.22 mIU/L [IQR 0.66-1.77 mIU/L] vs. 1.45 mIU/L [1.04-2.05 mIU/L], p = 0.001; third trimester: 1.74 mIU/L [IQR 1.08-2.36 mIU/L] vs. 1.93 mIU/L [IQR 1.37-2.58 mIU/L], p = 0.041) and higher fT4 values in the first trimester (M ± SD = 1.08 ± 0.14 ng/dL vs. 1.03 ± 0.12, p < 0.001) compared to those without nodules (n = 285). Both pregnant women with clinically significant thyroid nodules and those with nonsignificant ones had lower TSH values than women without nodules. CONCLUSIONS: TSH/fT4 reference intervals in pregnant women from the authors' geographical area will thyroid dysfunction in pregnancy to be appropriately diagnosed. The prevalence of thyroid nodules is high in iodine-sufficient pregnant women, and is associated with low TSH values across pregnancy.
引用
- Ollero MD, Toni M, Pineda JJ, et al. Thyroid Function Reference Values in Healthy Iodine-Sufficient Pregnant Women and Influence of Thyroid Nodules on Thyrotropin and Free Thyroxine Values. Thyroid. 2019. PMID: 30693851. doi:10.1089/thy.2018.0324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。